DrugPatentWatch Database Preview

Chartwell Rx Company Profile

« Back to Dashboard

What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?

CHARTWELL RX has forty-six approved drugs.

Summary for Chartwell Rx

US Patents:	0
Tradenames:	25
Ingredients:	22
NDAs:	46

Drugs and US Patents for Chartwell Rx

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Rx	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	TABLET;ORAL	088847-001	Feb 26, 1985		DISCN	No	No
Chartwell Rx	PHENTERMINE HYDROCHLORIDE	phentermine hydrochloride	CAPSULE;ORAL	085417-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Chartwell Rx	FULVICIN P/G 330	griseofulvin, ultramicrocrystalline	TABLET;ORAL	061996-004	Apr 6, 1982		DISCN	No	No
Chartwell Rx	FULVICIN P/G	griseofulvin, ultramicrocrystalline	TABLET;ORAL	061996-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Chartwell Rx	PHENDIMETRAZINE TARTRATE	phendimetrazine tartrate	TABLET;ORAL	085941-001	Jun 27, 1983		DISCN	No	No
Chartwell Rx	HYDROCHLOROTHIAZIDE	hydrochlorothiazide	TABLET;ORAL	085683-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Chartwell Rx	PHENTERMINE HYDROCHLORIDE	phentermine hydrochloride	CAPSULE;ORAL	088625-001	Aug 23, 1984		DISCN	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Chart Medcl
• Chartwell Life Sci
• Chartwell Molecular
• Chartwell Molecules
• Chartwell Pharma
• Chartwell Rx
• Chartwell Tetra